Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "Asthma"

127 News Found

Cipla launches next-generation oscillometer 'Ciposcillo' for respiratory diagnostics
Medical Device | May 06, 2026

Cipla launches next-generation oscillometer 'Ciposcillo' for respiratory diagnostics

The device is designed for early and accurate diagnosis of obstructive airway diseases such as COPD, and Asthma


Dr Odin launches ‘Odin Buddy’ kids’ nebulizer for child-friendly respiratory care
Medical Device | May 05, 2026

Dr Odin launches ‘Odin Buddy’ kids’ nebulizer for child-friendly respiratory care

New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents


Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit
Hospitals | May 05, 2026

Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit

Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.


C-mo wins CE Mark for AI-powered cough monitoring device, targets clinical trials market
News | April 16, 2026

C-mo wins CE Mark for AI-powered cough monitoring device, targets clinical trials market

The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance


Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
Biopharma | April 07, 2026

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline


Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
Biotech | April 06, 2026

Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial

Safety was equally impressive. ENV-294 was well tolerated


Novartis acquires Excellergy to bolster allergy portfolio
News | March 28, 2026

Novartis acquires Excellergy to bolster allergy portfolio

The move leverages Novartis’ deep expertise in IgE biology and long-standing presence in allergic disease treatments


Pfizer’s experimental atopic dermatitis drug shows strong Phase 2 results
Clinical Trials | March 11, 2026

Pfizer’s experimental atopic dermatitis drug shows strong Phase 2 results

The study hit its primary goal, showing a statistically significant rise in participants achieving EASI-75


GSK announces breakthrough data showing RSV vaccine cuts hospitalizations in elderly
Clinical Trials | February 19, 2026

GSK announces breakthrough data showing RSV vaccine cuts hospitalizations in elderly

The data highlights its RSV vaccine cuts hospitalizations in older adults


Beyfortus cuts RSV hospitalizations across two seasons in landmark study
News | February 17, 2026

Beyfortus cuts RSV hospitalizations across two seasons in landmark study

The NIRSE-GAL study, conducted in Galicia, Spain, is the first real-world, population-based investigation of a universal RSV immunization program spanning two consecutive seasons